US74267C1062 - Common Stock
PRA stock results show that ProAssurance beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
ProAssurance reports Q4 earnings: Non-GAAP EPS misses estimates by $0.10 and revenue beats expectations by $17.24M.
ProAssurance reported disappointing Q3 results with a Non-GAAP EPS miss of $0.23 and a revenue miss of $3.69M.
ProAssurance press release (PRA): Q2 Non-GAAP EPS of $0.16 beats by $0.04.Revenue of $291.83M (+14.1% Y/Y) beats by $19.91M.Shares +1.84%.
Vendor-neutral enterprise surgical data and intelligence platform, Caresyntax and ProAssurance (PRA) collaborate to provide innovative Caresyntax surgical intelligence tools...